Earth Science Tech (ETST) Change in Accured Expenses (2012 - 2026)
Earth Science Tech's (ETST) quarterly Change in Accured Expenses came in at -$200101.0 in Q1 2026, down 114.55% YoY from $1.4 million in Q1 2025, and up 84.05% on a QoQ basis from -$1.3 million in Q4 2025.
Earth Science Tech (ETST) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 11 years of Change in Accured Expenses data on file, last reported at -$200101.0 in Q1 2026.
- Quarterly Change in Accured Expenses fell 114.55% year-over-year to -$200101.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$968417.0 (down 167.69% YoY) and the FY2026 annual result came in at -$968417.0, down 167.69% from the prior year.
- Change in Accured Expenses improved to -$200101.0 in Q1 2026, from -$1.3 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.4 million in Q1 2025 to a low of -$1.3 million in Q4 2025.
- A 5-year average of $89720.2 and a median of $7000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses plunged 1663.51% — and 2025, when it surged 10622.08%.
- Tracing ETST's Change in Accured Expenses over 5 years: stood at -$839125.0 in 2022, then jumped by 100.83% to $7000.0 in 2023, then sank by 1663.51% to -$109446.0 in 2024, then plunged by 1045.99% to -$1.3 million in 2025, then soared by 84.05% to -$200101.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$200101.0 (Q1 2026), -$1.3 million (Q4 2025), and $155218.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Earth Science Tech | 35.67 Mn | 32.85 Mn | 6.28 Mn | 824,212.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 824,212.00 |
| Jun 30, 2026 | 824,212.00 |
| Mar 31, 2026 | -200,101.00 |
| Mar 31, 2026 | -200,101.00 |
| Dec 31, 2025 | -1.25 Mn |
| Dec 31, 2025 | -1.25 Mn |
| Sep 30, 2025 | 155,218.00 |
| Sep 30, 2025 | 155,218.00 |
| Jun 30, 2025 | 330,709.00 |
| Jun 30, 2025 | 330,709.00 |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -109,446.00 |
| Dec 31, 2024 | -109,446.00 |
| Sep 30, 2024 | 168,192.00 |
| Sep 30, 2024 | 168,192.00 |
| Jun 30, 2024 | -3,143.00 |
| Jun 30, 2024 | -3,143.00 |
| Mar 31, 2024 | 833,176.00 |
| Mar 31, 2024 | 833,176.00 |